Semaglutide
BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity
Novo Nordisk · Phase 3 · Not yet recruiting · Enrollment 352
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.